RBC Capital Upgrades Hologic to Outperform, Raises Price Target to $87

Benzinga · 08/06/2025 16:58
RBC Capital analyst Conor McNamara upgrades Hologic (NASDAQ:HOLX) from Sector Perform to Outperform and raises the price target from $72 to $87.